Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Diseases
we target
Diseases we target
Leber Hereditary Optic Neuropathy (LHON)
Retinitis Pigmentosa (RP)
Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Clinical development Summary
Investors
Company Overview
Financial press releases
Investor Newsletters
Events & presentations
Stock information & Financial agenda
Governance
Documentation
Media
Press Releases
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
News type
All
Regulatory
Clinical
Conferences
Corporate
Finance
General Meeting
Product candidates
Science & Technology
Other
Subject
All
General Assembly
Company and personnel
GS010 - LUMEVOQ
GS030
Technologies
Other
05 Oct 2020 - 06 Oct 2020
HealthTech Innovation Days (HTID®), Paris, France & Virtual Conference
30 Sep 2020
Ophthalmology Futures Retina – Virtual Forum
05 Oct 2020 - 06 Oct 2020
Chardan 4th Annual Genetic Medicines Conference – Virtual
14 Sep 2020 - 16 Sep 2020
H.C. Wainwright 22nd Annual Global Investment Conference – Virtual Conference
10 Sep 2020
OIS Retina Innovation Showcase
26 Jun 2020 - 27 Jun 2020
UMDF Power Surge 2020 – online event
24 Jul 2020 - 26 Jul 2020
2020 Annual Scientific Meeting ASRS – Virtual format
09 Jul 2020
KOL Call on LUMEVOQ® for the Treatment of Leber Hereditary Optic Neuropathy (LHON)
08 Jun 2020 - 12 Jun 2020
BIO 2020, San Diego (CA), US – Digital
03 May 2020 - 07 May 2020
2020 ARVO Annual Meeting, Baltimore (MD), US – cancelled
View previous 9 articles
1
2
3
4
5
6
7
8
9
10
11
…
17
View next 9 articles
Go back to the page of the page